Literature DB >> 365330

Tamoxifen in advanced breast cancer.

H Mouridsen, T Palshof, J Patterson, L Battersby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 365330     DOI： 10.1016/s0305-7372(78)80017-6

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  57 in total

Review 1.  Systemic therapy of advanced breast cancer.

Authors:  H T Mouridsen
Journal:  Drugs       Date:  1992       Impact factor: 9.546

2.  Changes in the hormone receptors of human breast carcinoma xenografts in nude mice by treatment with cytotoxic agents.

Authors:  J Koh; E Shiina; Y Hosoda; M Hashimoto; O Yamamoto; S Sakai; T Kubota; K Enomoto; O Abe
Journal:  Jpn J Surg       Date:  1990-01

3.  Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen.

Authors:  P E Budtz
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

Review 4.  [Current status in the treatment of breast cancer. I. Endocrine management--change of concepts and outlook for the future (author's transl)].

Authors:  U Jehn; H Sauer; W Wilmanns
Journal:  Klin Wochenschr       Date:  1979-09-17

5.  Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).

Authors:  J Alexieva-Figusch; W L Van Putten; H A van Gilse; J Blonk-vd Wijst; J G Klijn
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

Review 6.  Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

7.  Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships.

Authors:  K E Allen; E R Clark; V C Jordan
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  Update in cancer chemotherapy: general considerations and breast cancer, Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-08       Impact factor: 1.798

9.  Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer.

Authors:  E Heinonen; A Alanko; P Gröhn; P Rissanen
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 10.  Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.

Authors:  R J Santen
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.